Lithium improves survival of PC12 pheochromocytoma cells in high-density cultures and after exposure to toxic compounds by Fabrizi, C et al.
Research Article
Lithium Improves Survival of PC12 Pheochromocytoma Cells in
High-Density Cultures and after Exposure to Toxic Compounds
Cinzia Fabrizi,1 Stefania De Vito,1 Francesca Somma,1 Elena Pompili,1 Angela Catizone,1
Stefano Leone,2 Paola Lenzi,3 Francesco Fornai,3,4 and Lorenzo Fumagalli1
1 Department of Anatomy, Histology, Forensic Medicine and Orthopedics, Sapienza University, Via A. Borelli 50, 00161 Rome, Italy
2 Department of Science, Roma Tre University, Rome, Italy
3 Department of Human Morphology and Applied Biology, University of Pisa, Pisa, Italy
4 I.R.C.C.S. Neuromed, Pozzilli, Italy
Correspondence should be addressed to Cinzia Fabrizi; cinzia.fabrizi@uniroma1.it
Received 11 October 2013; Accepted 20 November 2013; Published 20 January 2014
Academic Editor: Claudia Giampietri
Copyright © 2014 Cinzia Fabrizi et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Autophagy is an evolutionary conserved mechanism that allows for the degradation of long-lived proteins and entire organelles
which are driven to lysosomes for digestion. Different kinds of stressful conditions such as starvation are able to induce autophagy.
Lithium and rapamycin are potent autophagy inducers with differentmolecular targets. Lithium stimulates autophagy by decreasing
the intracellular myo-inositol-1,4,5-triphosphate levels, while rapamycin acts through the inhibition of the mammalian target of
rapamycin (mTOR). The correlation between autophagy and cell death is still a matter of debate especially in transformed cells.
In fact, the execution of autophagy can protect cells from death by promptly removing damaged organelles such as mitochondria.
Nevertheless, an excessive use of the autophagic machinery can drive cells to death via a sort of self-cannibalism. Our data show
that lithium (used within its therapeutic window) stimulates the overgrowth of the rat Pheochromocytoma cell line PC12. Besides,
lithium and rapamycin protect PC12 cells from toxic compounds such as thapsigargin and trimethyltin. Taken together these data
indicate that pharmacological activation of autophagy allows for the survival of Pheochromocytoma cells in stressful conditions
such as high-density cultures and exposure to toxins.
1. Introduction
Pheochromocytoma is a rare neuroendocrine tumour
derived from chromaffin cells of the adrenal gland. Surgical
resection of the tumour is the treatment of choice and
usually results in cure of the hypertension related to the
excessive release of catecholamines. Approximately, 17% of
these tumours are malignant and treatment for metastatic
disease includes surgical resection and chemotherapy with
nonspecific agents which indiscriminately target dividing
cells [1].
A previous report indicates a possible novel strategy
for treatment of Pheochromocytomas and paragangliomas
showing that lithium determines a net reduction of the
growth in culture of the rat Pheochromocytoma cell line PC12
[2].
Lithium is already therapeutically widely used as a mood
stabilizer in the treatment of bipolar disorders and in human
patients levels of lithium in the serum are kept in the range
of 0.4–1.2mM [3]. Due to its diverse molecular targets, the
action of lithium may be complex and the interpretation of
its effects in biological systems is often controversial.
In fact, lithium is a monovalent cation with different
cellular targets depending on its concentration. At 0.5–1mM
it acts mainly as an inhibitor of inositol monophosphatase
(IMPase) (Ki 0.8mM) leading to free inositol depletion
and activating autophagy [4]. Autophagy is a catabolic
pathway which delivers cellular components to lysosomes
for digestion. First step is the engulfment of cytoplasmic
material or entire organelles in autophagosomes which later
on fuse with lysosomes to form autophagolysosomes. LC3
(microtubule-associated protein light chain 3) is localized in
Hindawi Publishing Corporation
International Journal of Cell Biology
Volume 2014, Article ID 135908, 7 pages
http://dx.doi.org/10.1155/2014/135908
2 International Journal of Cell Biology
autophagosomemembrane and is a widely appliedmarker for
autophagy [5].
Conversely, when used at high doses lithium inhibits
the glycogen synthase kinase-3 (GSK3) (Ki 1.5–2mM) and
reduces cellular proliferation and autophagy [6]. Two par-
alogs of GSK3 exist (GSK3𝛼 and GSK3𝛽) usually referred to
as isoforms because of their similar sequences and functions
although they are derived from different genes [7]. These
ubiquitously expressed serine/threonine kinases modulate
a large number of cellular functions and their activity is
inhibited by the phosphorylation of serine-21 in GSK3𝛼 and
serine-9 in GSK3𝛽.
Our data show that lithium if used in the range which
corresponds to its therapeutic window (0.5–1mM) favors
the proliferation and survival of the rat Pheochromocy-
toma cell line PC12. Consistently with an activation of the
autophagic pathway, 0.5mM lithium induces the appearance
of many autophagic vacuoles whereas the phosphoryla-
tion/inactivation of GSK3𝛼/𝛽 was observed only at a higher
lithium concentration (2mM).
2. Materials and Methods
2.1. Cell Cultures and Treatments. PC12 rat pheochromo-
cytoma cells (ECACC) were cultured in RPMI1640 and
DMEM/F12 (1 : 1) supplementedwith 5% foetal bovine serum,
10% horse serum, and 1% penicillin-streptomycin. Cells were
incubated at 37∘C in a humidified 5% CO
2
atmosphere and
medium was changed every three days.
PC12 cells were plated onto poly-L-ornithine-treated
glass coverslips in 24w plates (for fluorescence microscopy)
or directly in 6-well or 96-well plates (for western blot
analysis and assessment of neurotoxicity, resp.). PC12 cells
were treated with LiCl (0.5, 1, 2mM; Sigma) alone or
in combination with thapsigargin (100 nM) or trimethyltin
(TMT) (10 𝜇M;Heraeus, Karlsruhe,Germany). As for lithium
treatment, rapamycin (400 nM; Sigma) was used alone or
with TMT (1, 5, 10 𝜇M).
2.2. Proliferation Curve. PC12 cells were plated onto T25
culture flasks (5 × 105 cells/mL) in 5mL growth medium
without antibiotics. Every 24 hours cells were resuspended in
phosphate buffer and stained with Trypan blue. After 3 days
of culture further 5mL of growth medium was added. Viable
cells were counted in triplicate by a hemocytometer.
2.3. Assessment of Cell Death. The DNA fragmentation of
the apoptotic PC12 cells was detected using the termi-
nal deoxynucleotidyl transferase-mediated biotinylated UTP
nick end labeling (TUNEL) kit (In situ Cell Death Detec-
tion Kit, Roche). The cells were cultured on coverslips
for 24 hours and at the end of the drug treatment fixed
in 4% paraformaldehyde in phosphate buffer (pH 7.4) at
room temperature for 15min and then incubated with a
permeabilizing solution (0.1% Triton X-100) for 10min at
4∘C. The cells were incubated with the TUNEL reaction
mixture for 60min at 37∘C and visualized by inverted
fluorescence microscopy (Eclipse E600, Nikon Instruments
SpA, Italy). TUNEL-positive nuclei were counted in ten
nonoverlapping fields per coverslip and then converted to
percentage by comparing TUNEL-positive counts with the
total cell nuclei as determined by DAPI (4󸀠,6󸀠-diamino-2-
phenylindole) counterstaining.
Cell death was also evaluated by measuring the release
of lactate dehydrogenase (LDH) in the culture medium by
theCytotoxicityDetectionKit (Roche,Mannheim,Germany)
according to manufacturer’s protocols.
2.4. ElectronMicroscopy. PC12 cellswere treatedwith 0.5mM
lithium for 24 hours and then processed for electron
microscopy. After washing with phosphate buffer 0.1M (pH
7.4) samples were fixed in 0.1% glutaraldehyde and 2%
paraformaldehyde in phosphate buffer 0.1M (pH 7.4) for
1.30 hour at 4∘C. After washing with phosphate buffer 0.1M
(pH 7.4) samples were postfixed in 1% OsO
4
for 1 hour
at 4∘C and dehydrated in decreased series of ethanol and
embedded in Epoxy resin. Ultrathin sections (40–50 nm)
were cut at ultramicrotome. Sections were contrasted with
uranyl acetate (saturated solution in methanol) and lead
citrate and examined using a Jeol JEM SX 100 electron
microscope (Jeol, Tokyo, Japan).
2.5. Detection of Autophagic Vacuoles by Immunofluores-
cence. PC12 cells were treated for 24 hours with 0.5mM
lithium and then fixed in 4% paraformaldehyde in phosphate
buffer (pH 7.4) 1 hour at room temperature. After washings
nonspecific antibody binding sites were blocked with 10%
donkey serum (Sigma) and then cells were incubated for 1
hour at room temperature with a rabbit anti-LC3B antibody
(Sigma) and binding of the primary antibody visualized by
a secondary donkey Cy3-labelled-anti-rabbit-IgG (Jackson
ImmunoResearch Laboratories). Immunolocalization was
analyzed using a Leica confocal microscope (Laser Scanning
TCS SP2) (Leica Microsystems, Wetzlar, Germany) equipped
with Ar/ArKr and HeNe lasers. The images were scanned
under a 40X oil immersion objective with electronic zoom
of 2X and 4X. In order to perform a quantitative analysis,
spatial series through the 𝑧-axis each composed of 9-10
optical sections with a step size of 2𝜇m were performed
and maximal amplitude of fluorescence was evaluated as
described by [8] utilizing the Leica confocal software. No
significant fluorescent signal was detected with the secondary
antibody alone.
2.6. Western Blotting. Treated and untreated cells were
lysed in RIPA buffer containing protease and phosphatase
inhibitors (Protease Inhibitor Cocktail and Phosphatase
Inhibitor Cocktail 2, Sigma). Samples were clarified by
centrifugation at 1000 rpm for 5min. Equivalent amount of
protein (10 𝜇g) from each sample was electrophoretically
resolved on 12.5% precast SDS-polyacrylamide gels (Excel-
Gel, GE Healthcare Biosciences) using horizontal apparatus
(Pharmacia Biotech, Uppsala, Sweden). Then, separated pro-
teins were electrotransferred onto nitrocellulose membranes
(Schleicher & Schuell) by a semidry system (Novablot,
Pharmacia Biotech). Membranes were blocked with 5% BSA
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Figure 1: Proliferation curve of PC12 cells treatedwith lithium. Cells
were treated with 0.5mM lithium for 7 days and counted every day
with the Trypan blue exclusionmethod. Counts obtainedwith 5mM
lithium at 7 days are shown as reference. Averages ± SEM of three
independent experiments. ANOVA with Bonferroni’s-corrected 𝑡-
test. ∗𝑃 < 0.01 versus untreated control.
in PBS and then were incubated (overnight at 4∘C) with
the following monoclonal antibodies: GSK3𝛼/𝛽 (Sigma),
phospho-GSK3𝛼/𝛽 (Ser 21/9) (cell signalling). After extensive
washing with PBS containing 0.1% tween-20 (TBST), blots
were incubated with 1 : 2000 dilution of HRP-conjugated
secondary antibody (Amersham Biosciences) for 1 hour at
room temperature. Immunopositive bands were detected
with a chemiluminescence’s detection system (GE Health-
care Biosciences). To check for equal loading of the gel,
membranes were stripped and reprobed with mouse anti-
𝛽-actin antibody (1 : 20000, Sigma). Densitometric analysis
was performed with the Quantity One software (BioRad
Laboratories).
2.7. Statistics. Statistical analyses were conducted using
GraphPad Prism version 4.00 software. Data are expressed as
averages ± SEM. Comparisons were analysed using one-way
ANOVA with Bonferroni-corrected 𝑡-test. All experiments
were performed at least three times.
3. Results
As aforementioned, a previous report indicates lithium
as a possible novel treatment for pheocromocytomas and
paragangliomas [2]. Since lithium concentrations used in
that study were beyond its potential therapeutic use, we
decided to check the effect of lithium administration at the
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Figure 2: LDH release in the culture medium of PC12 cells treated
for 24 hours with 100 nM thapsigargin alone or in combination
with 0.5mM lithium. Lithium treatment significantly reduces the
thapsigargin-induced LDH release; a low but significant decrease
in LDH release is observed in cultures treated with lithium alone
with respect to the untreated control. Averages ± SEM of three
independent experiments. ANOVA with Bonferroni’s-corrected 𝑡-
test. ∗𝑃 < 0.01, ∗∗𝑃 < 0.001 versus untreated control.
concentration measured in sera of lithium-treated patients.
Similarly to Kappes and colleagues [2], we tested lithium
administration in the rat Pheochromocytoma cell line PC12
which is widely used for toxicity studies. We noticed that
after 5 days of culture 0.5mM lithium increases PC12 cell
number with respect to the untreated control, with this
effect remaining stable up to 7 days of culture (Figure 1).
A similar proliferation curve was obtained doubling the
concentration of lithium to 1mM while when PC12 cells
were seeded at low density (2 × 105/mL) neither 0.5mM nor
1mM lithium modified cell number with respect to control
(not shown). Interestingly, no significant differences between
treated and untreated cultures were observed before the
proliferation curve reaches the plateau. BrdU incorporation
analyses performed during the same period of time indicated
a similar rate of DNA synthesis in untreated and lithium-
treated cultures (not shown). Consistently with previously
published results [2], lithium used at the concentration of
5mM reduced cell number in PC12 cell cultures (Figure 1).
In order to check if lithium at 0.5mM was effective
in inhibiting PC12 cell death, we administered this cation
in combination with two different toxic molecules, thap-
sigargin and trimethyltin (TMT). As shown in Figure 2,
lithium was able to almost completely rescue PC12 cells
from thapsigargin-induced cell death. Similarly, lithium pro-
tected PC12 cells from TMT-induced apoptosis measured
by TUNEL at 24 hours (Figure 3(a)). At 24 hours of TMT
treatment PC12 cells seem to die mainly by apoptosis since
the release of LDH in the culture medium remained similar
to control (not shown). The release of LDH measured at 48
hours after TMT administration, which comprehends both
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Figure 3: Detection of TUNEL-positive cells (a) and release of LDH (b) in the culture medium of PC12 cells treated for 24 and 48 hours,
respectively, with 10𝜇MTMT alone or in combination with 0.5mM lithium. Lithium treatment completely reverses TMT-induced apoptosis
(a); a significant inhibition of LDH release is observed in PC12 cells treated with doses of lithium ranging from 0.5 to 2mM with respect to
cultures treated with TMT alone. Averages ± SEM of three independent experiments. ANOVA with Bonferroni’s-corrected 𝑡-test. ∗𝑃 < 0.01,
∗∗
𝑃 < 0.001 versus untreated control.
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Figure 4: Confocal microscopy of LC3B distribution in PC12 cells after treatment for 24 hours with 0.5mM lithium. Left panel: representative
image of control ((a), (b)) and lithium-treated samples ((c), (d)). Scale bars = 20𝜇m ((a), (c)); 40𝜇m ((b), (d)). (e): quantitative analysis. The
data represent the mean ± SE of maximal amplitude of fluorescence. ∗𝑃 < 0.001 versus control.
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Figure 5: Ultrastructural analysis of lithium-treated PC12 cells. Membrane-delimited vacuoles in the cytoplasm with the characteristic
features of autophagic vacuoles (arrows) are present in untreated cells (a) and more numerous in lithium-treated sample (b). Scale bars =
(a): 1 𝜇m; (b): 0.4 𝜇m.
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Figure 6: Rapamycin protects PC12 cultures from TMT toxicity.
Rapamycin (400 nM) limits the release of LDH in the culture
medium following 5–10𝜇M TMT exposure and its effect lasts up
to 72 hours. ANOVA with Bonferroni’s-corrected 𝑡-test. ∗𝑃 < 0.01
versus TMT alone.
necrosis and late apoptosis, was also reduced by lithium
(Figure 3(b)).
Since lithium is known to be able to activate the
autophagic pathway in different cellular systems, we checked
the presence of autophagic vesicles in lithium-treated PC12
cells.
The expression of the autophagosome marker LC3B was
evaluated by means of confocal microscopy in the control
and lithium-treated samples. In lithium-treated PC12 the
fluorescence intensity of LC3B was more evident and the
mean value of the maximal amplitude of fluorescence was
significantly increased (approximately 50%) with respect to
the control (Figure 4).
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Figure 7: Analysis of the level of GSK3 phosphorylation in PC12
cells treated with lithium (0.5, 1, 2mM) for 48 hours. Quantification
data of western blot analysis of the phosphorylation of GSK3𝛼
Ser21 and GSK3𝛽 Ser9. Averages ± SEM of three independent
experiments. ANOVA with Bonferroni’s-corrected 𝑡-test. ∗𝑃 < 0.01
versus untreated cells.
Many autophagic vesicles were also detected by electron
microscopy in lithium-treated cultures (Figure 5).
Besides, another known autophagy inducer such as
rapamycin similarly to lithiumwas effective in reducing TMT
neurotoxicity (Figure 6) confirming that a prompt activation
of the autophagic machinery can protect PC12 from cell
death.
We also checked in our cultures the phosphorylation
of GSK3 which is a well-known lithium target. The phos-
phorylation/inactivation of GSK3 resulted to be unchanged
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after treatment with 0.5mM lithium, while at 2mM a sta-
tistically significant increase in the phosphorylation of both
the GSK3𝛼 and GSK3𝛽 isoforms was measured with respect
to the untreated control (Figure 7).
4. Discussion
How the autophagic pathway can be involved in the pro-
gression of cancer is still a matter of controversy. In fact,
autophagy has been reported to participate in both tumour
suppression and tumour maintenance (for a recent review
see [9]). On the one hand, loss of genes which govern
the autophagic machinery such as beclin1 is observed in
various cancers [10]. On the other hand, autophagy by
limiting oxidative stress and supplying metabolic substrates
can promote tumour growth and maintenance [11, 12].
One way to reconcile these apparently conflicting results
is to speculate that the correct execution of autophagy
prevents the initial phase of tumourigenesis while later on
in the progression of cancer the same autophagic machinery
can be used by transformed cells to survive in adverse growth
conditions which are present inside a solid tumour due to the
limited blood supply.
In this connection, our data support this interpretation
indicating autophagy as a prosurvival mechanism for tumour
cells growing in a stressful environment, such as an overpop-
ulated culture.
As mentioned before, lithium has been proposed for the
treatment of Pheochromocytomas and paragangliomas [2].
These authors demonstrated that this cation can block the
proliferation of PC12 cells in culture. The minimum dose
of lithium showing this antiproliferative effect is 5mM and
thus far beyond its potential therapeutic use. In fact, lithium
has a narrow therapeutic window and well-known adverse
effects. Serum levels of lithium ranging from0.4 to 1.2mMare
effective in the treatment of bipolar disorders and showminor
side effects [3]. Conversely, prolonged exposures to serum
levels of 2mM lithium lead to renal and liver damage and
permanent neurological impairment is observed with plasma
levels above 2.5mM [13].
When we used lithium in a range of concentration cor-
responding to 0.5–1mM we observed a completely different
result with respect to Kappes and colleagues [2]. In fact, PC12
cells in the presence of 0.5mM lithium grow as the untreated
control during the first 3 days of culture showing a similar
exponential phase. Afterwards, in lithium-treated PC12 cells
a higher cellular number was reached with respect to control
at 5 days and maintained up to 7 days during the stationary
phase.These results are not consistent with a directmitogenic
activity of lithium. In particular, lithium seemed to favor the
growth of PC12 cells just in high-density cultures which likely
grow in stressful conditions due to shortage of nutrients and
accumulation of catabolites.
Besides, our data indicate that lithium at 0.5mM exerts
a neuroprotective action in PC12 cells treated with two toxic
molecules (thapsigargin and TMT) which act with different
mechanisms. Thapsigargin is a potent inhibitor of the Ca2+-
ATPase in the endoplasmic reticulum [14] and our results
are in agreement with a previous report which indicates
that lithium can revert thapsigargin toxicity in a range
of concentration from 0.5 to 4mM [15]. TMT is another
molecule highly toxic for PC12 cells determining a strong
loss of themitochondrialmembrane potential correlatedwith
an increased expression of bax/bcl-2 ratio [16]. TMT toxicity
relates to the expression of stannin, a highly conserved
protein mainly localized within mitochondria [17]. We show
here that in PC12 cultures the addiction of lithium reduces the
percentage of TUNEL-positive apoptotic nuclei completely
rescuing PC12 from TMT toxicity. Lithium administration
also limits the release of LDH in the culture medium which
is observed during necrotic cell death and in the late stages of
apoptosis. In agreementwith data reported here, our previous
results indicate that lithium (0.5–2mM) protects hippocam-
pal and cortical primary neurons from TMT-induced cell
death [18]. Moreover, 1.2mM lithium was also shown to
reverse the effect of morphine on the mRNA expression of
bax and bcl-2 in PC12 cells [19].
Lithium is a cation with a complex mechanism of action.
Its main molecular targets are IMPase and GSK3. For the
former the reported Ki is 0.8mM [4] while for the latter
it corresponds to 1.5–2mM [6]. Thus, it is very likely that
completely different biological effect of the same molecule
(lithium) can be observed just changing its concentration. In
this study we show the appearance of numerous autophagic
vesicles in PC12 cells after treatment with 0.5mM lithium
while at this low concentration of lithium the phospho-
rylation/inactivation of GSK3 was not observed. Besides,
lithium neuroprotection with respect to TMT toxicity can be
mimicked by a known autophagy inducer such as rapamycin.
Nevertheless, the neuroprotective effect of lithium observed
in our culture system can also be related to an increased
synthesis and release of trophic factors. In fact, long-term
lithium chronic treatment has been demonstrated to enhance
BDNF and NT-3 expression in vivo [20, 21].
We conclude that lithium when used at low doses
(0.5mM) can protect PC12 cells from toxicmolecules and can
also allow the overgrow of these cells in high-density cultures.
Thus, caution should be taken for the clinical use of this cation
in tumour bearing patients.
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